Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ATA-100 by Atamyo Therapeutics for Limb-Girdle Muscular Dystrophy: Likelihood of Approval
ATA-100 is under clinical development by Atamyo Therapeutics and currently in Phase II for Limb-Girdle Muscular Dystrophy. According to GlobalData,...